iLearningEngines Expects to Join the Russell 3000® Index
BETHESDA, Md., May 28, 2024 (GLOBE NEWSWIRE) — iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines” or “ILE”) a leading Applied AI platform […]
Inter&Co doubles down on SMEs through acquisition of Granito
BELO HORIZONTE, Brazil, May 28, 2024 (GLOBE NEWSWIRE) — Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), announces that Banco Inter […]
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative […]
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
First patient, first visit is planned for early June 2024 Enrollment has been expanded by 80% to a maximum of […]
Atlantica Enters into Agreement to be Acquired by Energy Capital Partners and Co-Investors
Atlantica Enters into Agreement to be Acquired by Energy Capital Partners and Co-Investors May 28, 2024 – Atlantica Sustainable Infrastructure […]
Cheer Holding Releases its First AIGC Children’s Animation Super Potato’s Adventure
BEIJING, May 28, 2024 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider […]
iQIYI, Inc. Announces Repurchase Right Notification for 4.00% Convertible Senior Notes due 2026
BEIJING, May 28, 2024 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online […]
Smart Share Global Limited to Report First Quarter 2024 Results on June 3, 2024
SHANGHAI, China, May 28, 2024 (GLOBE NEWSWIRE) — Smart Share Global Limited (“Energy Monster” or the “Company”), a consumer tech […]
FTAI Aviation Announces Internalization, Terminates Management and Advisory Agreement
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI) (“FTAI” or the “Company”) announced today it has […]
MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions
LA JOLLA, Calif., May 28, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
